↓ Skip to main content

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
2 news outlets
blogs
2 blogs
twitter
9 X users
patent
3 patents

Citations

dimensions_citation
121 Dimensions

Readers on

mendeley
194 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
Published in
Journal for Immunotherapy of Cancer, September 2017
DOI 10.1186/s40425-017-0277-7
Pubmed ID
Authors

Rocio Garcia-Carbonero, Ramon Salazar, Ignacio Duran, Ignacio Osman-Garcia, Luis Paz-Ares, Juan M. Bozada, Valentina Boni, Christine Blanc, Len Seymour, John Beadle, Simon Alvis, Brian Champion, Emiliano Calvo, Kerry Fisher

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 194 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 194 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 40 21%
Student > Bachelor 22 11%
Student > Master 20 10%
Student > Ph. D. Student 18 9%
Student > Doctoral Student 8 4%
Other 23 12%
Unknown 63 32%
Readers by discipline Count As %
Medicine and Dentistry 38 20%
Biochemistry, Genetics and Molecular Biology 32 16%
Immunology and Microbiology 16 8%
Pharmacology, Toxicology and Pharmaceutical Science 14 7%
Agricultural and Biological Sciences 11 6%
Other 10 5%
Unknown 73 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2021.
All research outputs
#948,715
of 25,837,817 outputs
Outputs from Journal for Immunotherapy of Cancer
#221
of 3,487 outputs
Outputs of similar age
#19,118
of 327,950 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#3
of 20 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,487 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,950 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.